Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XLO is expected to report earnings to rise 8.94% to -19 cents per share on August 06

Xilio Therapeutics XLO Stock Earnings Reports

Q2'25

Est.

$-0.20

Q1'25

Missed

by $0.37

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.01

The last earnings report on May 08 showed earnings per share of -18 cents, missing the estimate of 18 cents. With 143.90K shares outstanding, the current market capitalization sits at 36.76M.

View a ticker or compare two or three

Compare

XLO